INOVIO Pharmaceuticals

Innovation Meets Acceleration: INOVIO Advances in Treatment for Respiratory Disease and Beyond

PLYMOUTH MEETING, PA — Biotechnology company INOVIO (NASDAQ: INO) is making considerable strides with its lead program, INO-3107, aimed at addressing Recurrent Respiratory Papillomatosis (RRP). This progress, backed by encouraging …

Innovation Meets Acceleration: INOVIO Advances in Treatment for Respiratory Disease and Beyond Read More